Crossmark

A comparison of diagnostic and therapeutic approaches for Mycoplasma pneumoniae pneumonia in children and adults, during the post-COVID-19 pandemic era

Crossref DOI link: https://doi.org/10.1007/s10096-025-05142-4

Published Online: 2025-04-29

Published Print: 2025-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Yue, Hongjuan

Sheng, Qihong

Wang, Xiaoyu

Cheng, Zishuo

Zhang, Mei

Wang, Qian

Wang, Lihong

Yu, Weifang

Zhai, Congjie

Wang, Jia
Funding

Funding for this research was provided by:

Natural Science Foundation of Hebei Province (H2024206140, H2024206140, H2022206292, H2024206140, H2024206140, H2024206140, H2024206140, H2024206140, H2024206140, H2024206140)

the Key R&D Program of Hebei Province (223777103D)

the Hebei Provincial Government-funded Provincial Medical Excellent Talent Project (ZF2023025)

Hebei Provincial Government-funded Provincial Medical Excellent Talent Project (LS202212)
License Information

Text and Data Mining valid from 2025-04-29

Version of Record valid from 2025-04-29
More Information

Article History

Received: 11 March 2025

Accepted: 21 April 2025

First Online: 29 April 2025

Declarations

:

: This study was approved by the Ethics Committee of the First Hospital of Hebei Medical University (Ethics Approval No. S00973). This study is in line with the Helsinki Declaration. Clinical trial number: not applicable.

: The legal guardians of minor patients and all adult patients included in the study have signed informed consent forms.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below